Inflammatory Bowel Disease Market at Risk of Contraction
Experts emphasize the necessity for new biologics to outshine existing therapies to justify their cost, fostering innovation in the IBD market's evolution.
Stay updated with breaking news from Adeleke Badejo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts emphasize the necessity for new biologics to outshine existing therapies to justify their cost, fostering innovation in the IBD market's evolution.
As biosimilars and next-generation treatments for Crohn’s disease enter the market, AbbVie will be knocked from its place of longtime dominance, contends data and analytics firm GlobalData.
01 Jun, 2023 AbbVie's Rinvoq for Crohn's Disease to see rapid uptake by healthcare providers, says GlobalData Share Print... | June 1, 2023
The Department of Economics, University of Ibadan (UI), has presented the inaugural Abdul-Lateef Babatunde Ajao Best Graduating Economics